Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts

OBJECTIVES: The effectiveness of evaluation of the severity of epidermal growth-factor receptor inhibitor (EGFRI)-associated dermatological toxicities remains a topic of debate. This study was designed to assess the correlation between quality of life (QoL) and severity of dermatological toxicity, e...

Descripción completa

Detalles Bibliográficos
Autores principales: De Tursi, Michele, Zilli, Marinella, Carella, Consiglia, Auriemma, Matteo, Lisco, Maria Nadia, Di Nicola, Marta, Di Martino, Giuseppe, Natoli, Clara, Amerio, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481280/
https://www.ncbi.nlm.nih.gov/pubmed/28670133
http://dx.doi.org/10.2147/OTT.S127795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481280/
https://www.ncbi.nlm.nih.gov/pubmed/28670133
http://dx.doi.org/10.2147/OTT.S127795

Ejemplares similares